Viking Therapeutics, Inc. (VKTX)
NASDAQ: VKTX · IEX Real-Time Price · USD
51.54
-3.78 (-6.83%)
At close: Jul 2, 2024, 4:00 PM
51.77
+0.23 (0.45%)
After-hours: Jul 2, 2024, 7:57 PM EDT
Viking Therapeutics Market Cap
Viking Therapeutics has a market cap or net worth of $5.68 billion as of July 2, 2024. Its market cap has increased by 179.75% in one year.
Market Cap
5.68B
Enterprise Value
4.72B
1-Year Change
179.75%
Ranking
Category
Stock Price
$51.54
Market Cap Chart
Since April 29, 2015, Viking Therapeutics's market cap has increased from $77.50M to $5.68B, an increase of 7,233.18%. That is a compound annual growth rate of 59.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 1, 2024 | 6.10B | 227.69% |
| Dec 29, 2023 | 1.86B | 158.22% |
| Dec 30, 2022 | 720.90M | 100.31% |
| Dec 31, 2021 | 359.90M | -12.37% |
| Dec 31, 2020 | 410.70M | -29.14% |
| Dec 31, 2019 | 579.60M | 6.02% |
| Dec 31, 2018 | 546.70M | 372.52% |
| Dec 29, 2017 | 115.70M | 382.08% |
| Dec 30, 2016 | 24.00M | -27.27% |
| Dec 31, 2015 | 33.00M | -57.42% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Revolution Medicines | 6.40B |
| Acadia Healthcare Company | 6.27B |
| Cytokinetics | 6.21B |
| Madrigal Pharmaceuticals | 5.97B |
| Glaukos | 5.96B |
| Tempus AI | 5.78B |
| Lantheus Holdings | 5.57B |
| Summit Therapeutics | 5.48B |